Richard Knox

Since he joined NPR in 2000, Knox has covered a broad range of issues and events in public health, medicine, and science. His reports can be heard on NPR's Morning Edition, All Things Considered, Weekend Edition, Talk of the Nation, and newscasts.

Among other things, Knox's NPR reports have examined the impact of HIV/AIDS in Africa, North America, and the Caribbean; anthrax terrorism; smallpox and other bioterrorism preparedness issues; the rising cost of medical care; early detection of lung cancer; community caregiving; music and the brain; and the SARS epidemic.

Before joining NPR, Knox covered medicine and health for The Boston Globe. His award-winning 1995 articles on medical errors are considered landmarks in the national movement to prevent medical mistakes. Knox is a graduate of the University of Illinois and Columbia University. He has held yearlong fellowships at Stanford and Harvard Universities, and is the author of a 1993 book on Germany's health care system.

He and his wife Jean, an editor, live in Boston. They have two daughters.

Pages

Shots - Health Blog
2:24 pm
Wed July 18, 2012

HIV Cure Is Closer As Patient's Full Recovery Inspires New Research

Nurse Priscila-Grace Gonzaga with Gregg Cassin, a San Francisco gay man who has been infected with HIV since the early 1980s. He's a volunteer in a cutting-edge gene therapy experiment to see whether HIV-infected people can be given an immune system that is invulnerable to HIV infection.
Richard Knox NPR

Originally published on Wed July 18, 2012 4:30 pm

Ask AIDS researchers why they think a cure to the disease is possible and the first response is "the Berlin patient."

That patient is a wiry, 46-year-old American from Seattle named Timothy Ray Brown. He got a bone marrow transplant five years ago when he was living in Berlin.

Read more
Shots - Health Blog
11:17 am
Tue July 17, 2012

Cholera Vaccination Test Reached Targets In Haiti

A lone pig roots through trash dumped over the side of a sewage canal that runs from the center of Port au Prince through Cite de Dieu. During the rainy season, the canal overflows its banks and fills nearby houses with sewage, which can carry cholera.
John W. Poole NPR

The results are in on this spring's high-visibility pilot project to vaccinate 100,000 Haitians against cholera.

Almost 90 percent of the target population – half in Port-au-Prince and the other half in a remote rural area – got fully protected against cholera, meaning they got 2 doses of the oral vaccine.

The results defy the forecasts of skeptics who said in advance of the campaign that it would be lucky to protect 60 percent of the target populations.

Read more
Shots - Health Blog
12:05 am
Tue July 17, 2012

Deciding On Truvada: Who Should Take New HIV Prevention Pill?

Kevin Kirk (left) and James Callahan have been together for more than five years. Recently they sat down and talked about whether Kevin, who is HIV-negative, might want to start taking Truvada.
Richard Knox NPR

Originally published on Sat July 28, 2012 8:05 am

There's something new to prevent HIV infections.

The Food and Drug Administration on Monday approved a once-a-day pill that can drastically lower a person's risk of getting the virus that causes AIDS.

It's called Truvada — the first HIV prevention pill.

It's not cheap — around $13,000 a year — and it's not clear what insurers will pay for it. And there's worry that people taking the pill might relax safe-sex precautions.

Read more
AIDS: A Turning Point
12:06 am
Thu July 12, 2012

'Treatment As Prevention' Rises As Cry In HIV Fight

While Kenya Jackson (right) is on his thrice-weekly dialysis treatment, community health worker Greg Jules talks to him about taking his medication.
Richard Knox NPR

Originally published on Thu July 12, 2012 9:21 am

AIDS researchers, policymakers and advocates are increasingly convinced that treating HIV is one of the best ways of preventing its spread.

The rallying cry is "treatment as prevention," and it's the overarching theme of this month's International AIDS Conference in Washington, D.C.

Read more
Shots - Health Blog
3:15 pm
Tue July 3, 2012

New Home Test For HIV May Cut Down New Infections

The Food and Drug Administration just approved the OraQuick test, which detects the presence of HIV in saliva collected using a mouth swab.
Chuck Zovko AP

Originally published on Thu July 5, 2012 7:38 am

No infectious disease has ever been detectable by a test that consumers can buy over the counter and get quick results at home. But HIV isn't just any infection. It's a stubborn pandemic virus that's still making people sick and killing them 31 years after it first appeared – even though infection is easily prevented and effectively treated.

Read more

Pages